Page last updated: 2024-09-03

ro 8-0576 and Parkinson Disease, Secondary

ro 8-0576 has been researched along with Parkinson Disease, Secondary in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	2 (28.57)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Che, NN; Chen, SY; Li, X; Ma, JJ; Yang, HQ	1
Gu, SD; Sun, XF; Wang, W; Zhao, DZ	1
Kamenetskiĭ, VK	1
Prevett, MC; Rossor, MN	1
Chen, S	1
Campanella, G; De Michele, G; Filla, A; Mengano, A; Trombetta, L	1
Caraceni, T; Lamperti, E; Lorizio, A; Nordera, N	1

Trials

1 trial(s) available for ro 8-0576 and Parkinson Disease, Secondary

Article	Year
A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease. Acta neurologica, 1989, Volume: 11, Issue:6 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary	1989

Other Studies

6 other study(ies) available for ro 8-0576 and Parkinson Disease, Secondary

Article	Year
Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment. Journal of neuroimmunology, 2021, 12-15, Volume: 361 Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiparkinson Agents; Autoantibodies; Benserazide; Cognitive Dysfunction; Drug Combinations; Fever of Unknown Origin; Handwriting; Humans; Immunosuppressive Agents; Immunotherapy; Levodopa; Male; Methylprednisolone; Neuropsychological Tests; Parkinson Disease, Secondary; Tremor	2021
[The effect of shourong compound formula on levels of dopamine and its metabolites in brain of Parkinson's disease mice induced by reserpine]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2002, Volume: 27, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Brain; Dopamine; Drug Combinations; Drug Synergism; Drugs, Chinese Herbal; Homovanillic Acid; Levodopa; Male; Mice; Parkinson Disease, Secondary; Plant Extracts; Plants, Medicinal; Reserpine	2002
[Treatment of patients with vascular parkinsonism with the preparations nakom and madopar]. Klinicheskaia meditsina, 1984, Volume: 62, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease, Secondary	1984
Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Acute Disease; Adult; Antiparkinson Agents; Benserazide; Cystic Fibrosis; Drug Combinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Pons	1999
[Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1992, Volume: 25, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamines; Animals; Apomorphine; Benserazide; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca mulatta; Parkinson Disease, Secondary	1992
Madopar HBS and the decompensated phase of Parkinson disease. Italian journal of neurological sciences, 1989, Volume: 10, Issue:4 Topics: Adult; Aged; Benserazide; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary	1989